Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)
China · Delayed Price · Currency is CNY 5.06
+0.46 (10.00%)
Apr 9, 2026, 3:00 PM CST
SHA:600594 Revenue
Guizhou Yibai Pharmaceutical had revenue of 453.58M CNY in the quarter ending September 30, 2025, a decrease of -16.87%. This brings the company's revenue in the last twelve months to 1.91B, down -20.47% year-over-year. In the year 2024, Guizhou Yibai Pharmaceutical had annual revenue of 2.17B, down -22.92%.
Revenue (ttm)
1.91B
Revenue Growth
-20.47%
P/S Ratio
2.08
Revenue / Employee
362.46K
Employees
5,261
Market Cap
3.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.17B | -646.53M | -22.92% |
| Dec 31, 2023 | 2.82B | 85.30M | 3.12% |
| Dec 31, 2022 | 2.74B | -611.44M | -18.27% |
| Dec 31, 2021 | 3.35B | -66.49M | -1.95% |
| Dec 31, 2020 | 3.41B | 52.17M | 1.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Well Pharmaceutical Group | 1.31B |
| Shaanxi Panlong Pharmaceutical Group Limited By Share | 1.10B |
| Hunan Hansen Pharmaceutical | 1.05B |
| Anhui Sunhere Pharmaceutical Excipients | 934.72M |
| Harbin Medisan Pharmaceutical | 874.60M |
| Shandong Wohua Pharmaceutical | 816.95M |
| Qianjiang Yongan Pharmaceutical | 797.25M |
| Zhejiang Cheng Yi Pharmaceutical | 790.86M |